Jardiance 10 MG tablet 90S
Ended Awarded Last action
- Contract number
- SPE2DR26F9L33
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $25,470
Award facts
- Contract value 100% obligated
- $25,469.54 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency has awarded a delivery order valued at $25,469.54 to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count packages). This firm fixed-price, non-set-aside contract was awarded on December 2, 2025, with an ultimate completion date of December 3, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 prime vendor agreement running through December 2026 that enables the company to supply comprehensive pharmaceutical and medical products to support military healthcare programs globally.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal medical procurement vendor that serves the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's extensive contract portfolio demonstrates its capability to meet federal procurement requirements through competitive award processes, with delivery orders covering a wide spectrum of pharmaceutical products including specialty medications, brand-name and generic drugs, and medical supplies across multiple therapeutic domains. The DLA plans to establish the Pharmaceutical Prime Vendor Global Program Generation V contracts with multiple awards across separate regions, positioning AmerisourceBergen as a key supplier within this strategic procurement framework for military and veteran healthcare systems.
Quick answers
Who was awarded contract SPE2DR26F9L33?
SPE2DR26F9L33 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 2, 2025.
How much is contract SPE2DR26F9L33 worth?
The government has obligated $25,470 on SPE2DR26F9L33.
Is contract SPE2DR26F9L33 an order under another contract?
Yes. SPE2DR26F9L33 is a delivery order under SPE2DR25D3103, an indefinite delivery contract.
Was contract SPE2DR26F9L33 competed?
The extent of competition for SPE2DR26F9L33 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award